Search research articles
Contact Us
Filters
Showing results (311-320 of 361) with videos related to
Page
of 37
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
October 24, 2025
Total Body Irradiation-Based Versus Chemotherapy-Alone Myleloblative Conditioning Regimen Before Hematopoietic Allogeneic Stem Cell Transplantation in Adults With Acute Lymphoblastic Leukemia: A Multi-Institutional Study From the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Yazid Belkacemi, Kamel Debbi, Nhu Hanh To, et al.
Transplantation and Cellular Therapy
|
March 7, 2024
Umbilical Cord Blood Transplantation for Fanconi Anemia With a Special Focus on Late Complications: a Study on Behalf of Eurocord and SAAWP-EBMT
Hanadi Rafii, Fernanda Volt, Marc Bierings, et al.
Plos One
|
July 9, 2024
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients
Francesca Bettelli, Daniela Vallerini, Ivana Lagreca, et al.
Frontiers in Oncology
|
October 27, 2022
Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis
Jesse M Tettero, Waleed K W Al-Badri, Lok Lam Ngai, et al.
Bone Marrow Transplantation
|
September 10, 2025
Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working Party
Agnieszka Piekarska, Mouad Abouqateb, William Boreland, et al.
American Journal of Hematology
|
November 27, 2023
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT
Alicia Rovó, Luuk Gras, Brian Piepenbroek, et al.
Blood
|
October 11, 2012
Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK)
Gert J Ossenkoppele, Georg Stussi, Johan Maertens, et al.
Bone Marrow Transplantation
|
November 18, 2023
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
Alexandros Spyridonidis, Myriam Labopin, Tobias Gedde-Dahl, et al.
Plos One
|
February 13, 2016
Mucorales-Specific T Cells in Patients with Hematologic Malignancies
Leonardo Potenza, Daniela Vallerini, Patrizia Barozzi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 30, 2022
Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer
Johan Maertens, Tom Lodewyck, J Peter Donnelly, et al.
Page
of 37
Search research articles
Search
Showing results (311-320 of 361) with videos related to
Sort By:
Page
of 37
International Journal of Radiation Oncology, Biology, Physics
|
October 24, 2025
Total Body Irradiation-Based Versus Chemotherapy-Alone Myleloblative Conditioning Regimen Before Hematopoietic Allogeneic Stem Cell Transplantation in Adults With Acute Lymphoblastic Leukemia: A Multi-Institutional Study From the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Yazid Belkacemi, Kamel Debbi, Nhu Hanh To, et al.
Transplantation and Cellular Therapy
|
March 7, 2024
Umbilical Cord Blood Transplantation for Fanconi Anemia With a Special Focus on Late Complications: a Study on Behalf of Eurocord and SAAWP-EBMT
Hanadi Rafii, Fernanda Volt, Marc Bierings, et al.
Plos One
|
July 9, 2024
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients
Francesca Bettelli, Daniela Vallerini, Ivana Lagreca, et al.
Frontiers in Oncology
|
October 27, 2022
Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis
Jesse M Tettero, Waleed K W Al-Badri, Lok Lam Ngai, et al.
Bone Marrow Transplantation
|
September 10, 2025
Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working Party
Agnieszka Piekarska, Mouad Abouqateb, William Boreland, et al.
American Journal of Hematology
|
November 27, 2023
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT
Alicia Rovó, Luuk Gras, Brian Piepenbroek, et al.
Blood
|
October 11, 2012
Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK)
Gert J Ossenkoppele, Georg Stussi, Johan Maertens, et al.
Bone Marrow Transplantation
|
November 18, 2023
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
Alexandros Spyridonidis, Myriam Labopin, Tobias Gedde-Dahl, et al.
Plos One
|
February 13, 2016
Mucorales-Specific T Cells in Patients with Hematologic Malignancies
Leonardo Potenza, Daniela Vallerini, Patrizia Barozzi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 30, 2022
Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer
Johan Maertens, Tom Lodewyck, J Peter Donnelly, et al.
Page
of 37